Amgen Balance Sheet Health
Financial Health criteria checks 1/6
Amgen has a total shareholder equity of $5.0B and total debt of $64.0B, which brings its debt-to-equity ratio to 1274.8%. Its total assets and total liabilities are $93.0B and $88.0B respectively. Amgen's EBIT is $7.1B making its interest coverage ratio 2.2. It has cash and short-term investments of $9.7B.
Key information
1,274.8%
Debt to equity ratio
US$64.02b
Debt
| Interest coverage ratio | 2.2x |
| Cash | US$9.71b |
| Equity | US$5.02b |
| Total liabilities | US$87.96b |
| Total assets | US$92.98b |
Recent financial health updates
Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Recent updates
Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26The Price Is Right For Amgen Inc. (NASDAQ:AMGN)
Jul 11Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 05Amgen: You Haven't Seen Anything Yet
Jun 17Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
Jun 04Amgen Stock: Poised To Break Out (Technical Analysis)
May 21Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?
May 04Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
May 01Amgen: The Giant With An Impressive Pipeline
Apr 15Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
Mar 31Amgen Will Benefit From Increased Medical Spending
Mar 12Amgen: A Good Dividend Growth Stock For The Watch List
Mar 04Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit
Feb 21Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now
Feb 16Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
Feb 08Amgen: Accelerating The Business And Dividend Growth
Jan 29Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?
Jan 29Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
Jan 22Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors
Dec 13Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?
Oct 23Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?
Sep 04Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13
Aug 05Amgen Inc. (NASDAQ:AMGN) Shares Could Be 45% Below Their Intrinsic Value Estimate
May 30Financial Position Analysis
Short Term Liabilities: AMGN's short term assets ($28.0B) exceed its short term liabilities ($19.7B).
Long Term Liabilities: AMGN's short term assets ($28.0B) do not cover its long term liabilities ($68.2B).
Debt to Equity History and Analysis
Debt Level: AMGN's net debt to equity ratio (1081.5%) is considered high.
Reducing Debt: AMGN's debt to equity ratio has increased from 304.9% to 1274.8% over the past 5 years.
Debt Coverage: AMGN's debt is not well covered by operating cash flow (12.6%).
Interest Coverage: AMGN's interest payments on its debt are not well covered by EBIT (2.2x coverage).